Literature DB >> 11823494

CpG oligodeoxynucleotides as vaccine adjuvants in primates.

Daniela Verthelyi1, Richard T Kenney, Robert A Seder, Albert A Gam, Brenda Friedag, Dennis M Klinman.   

Abstract

Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal models are needed to monitor the activity and safety of "human" CpG ODN in vivo. This work demonstrates that rhesus macaques recognize and respond to the same CpG motifs that trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania vaccine provided significantly increased protection of macaques against cutaneous Leishmania infection. These findings indicate that rhesus macaques provide a useful model for studying the in vivo activity of human CpG motifs, and that ODN expressing these motifs act as strong immune adjuvants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823494     DOI: 10.4049/jimmunol.168.4.1659

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

Authors:  Igor M Belyakov; Scott A Hammond; Jeffrey D Ahlers; Gregory M Glenn; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses.

Authors:  Camilo Cuadros; Francisco J Lopez-Hernandez; Ana Lucia Dominguez; Michael McClelland; Joseph Lustgarten
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 3.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

Authors:  Igor M Belyakov; Vladimir A Kuznetsov; Brian Kelsall; Dennis Klinman; Marcin Moniuszko; Michael Lemon; Phillip D Markham; Ranajit Pal; John D Clements; Mark G Lewis; Warren Strober; Genoveffa Franchini; Jay A Berzofsky
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

5.  Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.

Authors:  Frances Rena Bahjat; Rebecca L Williams-Karnesky; Steven G Kohama; G Alexander West; Kristian P Doyle; Maxwell D Spector; Theodore R Hobbs; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

6.  Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.

Authors:  Sean P McBurney; Gary Landucci; Donald N Forthal; Ted M Ross
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-21       Impact factor: 2.205

7.  Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.

Authors:  Barbara Flynn; Vivian Wang; David L Sacks; Robert A Seder; Daniela Verthelyi
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Scrub typhus vaccine candidate Kp r56 induces humoral and cellular immune responses in cynomolgus monkeys.

Authors:  Suchismita Chattopadhyay; Ju Jiang; Teik-Chye Chan; T Scott Manetz; Chien-Chung Chao; Wei-Mei Ching; Allen L Richards
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

9.  Tonsillar application of AT-2 SIV affords partial protection against rectal challenge with SIVmac239.

Authors:  Panagiotis Vagenas; Vennansha G Williams; Michael Piatak; Julian W Bess; Jeffrey D Lifson; James L Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

10.  Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice.

Authors:  Byong Jun Lee; Soo Kie Kim; Moon Kyu Kim; Eon Sub Park; Hyun Chul Cho; Myung Sook Shim; Mi Jin Kim; Young Goo Shin; Choon Hee Chung
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.